Advertising
0
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »
BUY
Credit card sized pouch inserted under the skin into which insulin cells are inserted. Control highs and lows of insulin. Also works with thyroid cells. Distribution platform for many drugs. Very positive. Revolutionary. His 12-month price target is $2.50-3, subject to outcome of trials.
0
BUY
They produce a credit card-size device beneath the skin to produce to produce insulin and regulate body sugar levels. This helps diabetics and those with thyroid conditions. Testing results have been positive. He's optimistic about this.
0
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock probably has some legs. The Type 1 diabetes treatment they are working on is getting lots of attention. Trials continue to show results and they have raised money and signed agreements with large companies. It is a new biotech play and the potential market is very large. Unlock Premium - Try 5i Free

0
BUY
Disclosure: He's helped with 2-3 of their financings recently. They make a credit-card sized pouch inserted under the skin that produces insulin to reduce extreme high or low insulin levels. That pouch can be used for many other applications in the future. Results are coming soon. SVA has broken out from 30 cents to 70 before the reports. There are strong opportunities for them in the coming year with potential deals with drugmakers and distributors.
0
BUY
They make a tiny device that you implant into your chest to create insulin. The medical benefits are high and could have additional applications. Tests are exploring how the device can deliver other drugs into the body, and early results are promising. He sees a lot of upside.
0
BUY
The company is researching insulin therapy delivery technology. They are moving into human trials. It has potential to go beyond insulin delivery systems to other drugs as well.
0
BUY
He participated in a recent financing. They have a piece that is inserted under the skin and then inject it with insulin. There are plans to use this for other needs as well.
0
BUY
They have an interesting implantable device that functions as an artificial pancreas. This replaces injecting insulin into diabetics. They are moving towards testing on people. It is quite positive.
0
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Sernova Corp.(SVA-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Sernova Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Sernova Corp.(SVA-X) Frequently Asked Questions

What is Sernova Corp. stock symbol?

Sernova Corp. is a Canadian stock, trading under the symbol SVA-X on the TSX Venture Exchange (SVA-CV). It is usually referred to as TSXV:SVA or SVA-X

Is Sernova Corp. a buy or a sell?

In the last year, 4 stock analysts published opinions about SVA-X. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Sernova Corp..

Is Sernova Corp. a good investment or a top pick?

Sernova Corp. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sernova Corp..

Why is Sernova Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Sernova Corp. worth watching?

4 stock analysts on Stockchase covered Sernova Corp. In the last year. It is a trending stock that is worth watching.

What is Sernova Corp. stock price?

On 2021-12-01, Sernova Corp. (SVA-X) stock closed at a price of $1.29.